アステラス製薬

As we approach the end of 2024, we reflect on our journey and the partnerships that have helped us shape the future of healthcare. At Astellas, we are committed to turning innovative science into VALUE for patients, and we are proud of the progress we have made together. We extend our warmest wishes for joy and health to all our stakeholders this holiday season. Your support and collaboration have been instrumental in our achievements, and we look forward to continuing this important mission together in the year ahead. #innovation #partnerships #healthcare

We’re proud to share that Astellas has entered into a license agreement with Sangamo Therapeutics, Inc., which will allow us to leverage Sangamo’s novel proprietary neurotropic adeno-associated virus (#AAV) capsid, STAC-BBB, to deliver gene therapies to treat certain #NeurologicalDiseases.     This agreement reinforces our ongoing commitment to the gene therapy field and turning innovative science into VALUE for patients.  Learn more:  https://lnkd.in/g9hsJV-x

In a landscape where many pharmaceutical companies are calling for a return to the office, Astellas is taking a bold step in the opposite direction. Our Chief People Officer and Chief Ethics & Compliance Officer, Katsuyoshi Sugita, recently shared insights on how our commitment to a flexible working environment is not just a trend—it's a strategy for attracting and retaining top talent. At Astellas, we trust our employees to deliver results, whether they work in the office once a year, once a quarter or every day. This flexibility is a key factor in attracting individuals with a patient-first mindset who thrive in a transformative environment.    Kats also emphasizes the importance of preserving the unique cultures of acquired companies, fostering innovation and ownership. As we continue to grow, we remain dedicated to creating a workplace where each culture is respected, and talents can flourish.     Read full article: https://lnkd.in/gtNSHxdv HR Executive #FlexibleWork #TalentAttraction #pharmaceuticals

We are proud to launch our second Astellas Healthcare E-city in Brazil. This innovative digital experience delivers health information, education, and support about vasomotor symptoms during menopause to reach Brazilians in urban and rural communities. Visitors can also navigate to the first E-city with gastric cancer resources.  This is the latest milestone in our commitment to improving Access to Health as we collaborate with external partners to help strengthen health systems and improve healthcare literacy. Learn more: https://bit.ly/4gjMLVM #AccessToHealth #HealthcareInnovation #HealthLiteracy

At Astellas, we recognize that fostering robust partnerships with ambitious innovators across pharma, biotech, academia and beyond is essential for advancing #ScientificInnovation in today’s complex landscape. Issei Tsukamoto, Head of Business Development, emphasizes how our unique approach to collaboration can accelerate the delivery of #TransformativeTherapies to patients, sooner. Please read the full article to gain insights into how we are building dynamic and flexible partnerships and how we are working to bring groundbreaking science to fruition.  https://lnkd.in/gDGTQu7a

We’re excited to share that Nick Eshkenazi, our Chief Digital & Transformation Officer, has been recognized by CIO Outlook with the prestigious award as a Top 10 Chief Digital Officer in APAC for 2024. This recognition reflects Nick's efforts in advancing Astellas' digital transformation journey, including the integration of generative AI tools and in-house LLMs (Large Language Models) as we nurture a culture of continuous experimentation, exploration and evolution. These innovations and approaches are helping us improve productivity, foster agility, and continue delivering VALUE for patients. Congratulations to Nick on this achievement and thank you for your leadership in navigating this evolving landscape. Read more about the award and his approach to driving digital transformation at Astellas: https://lnkd.in/ggq9WsJe #DigitalTransformation

Our CEO Naoki Okamura recently joined other Asia Pacific leaders for a virtual CEO roundtable discussion hosted by Diane Brady at Fortune. As the only #healthcare leader in attendance, Naoki highlighted the unique business and regulatory environment in which #pharmaceutical companies create innovation and deliver VALUE for patients worldwide.  Throughout the discussion, the leaders in attendance found common ground on the importance of #AI in enhancing our business practices and our embrace of globalization to achieve growth and success beyond Asia Pacific region. https://lnkd.in/gZtqpfZp

Astellas is proud to celebrate #HumanRightsDay with the international community. The Universal Declaration of Human Rights by the United Nations was adopted on December 10, 1948. This global pledge represents a milestone for universal protections for human rights. We uphold a high standard of respect for #HumanRights worldwide through our employee code of conduct, business operations, and labor standards.   As a signatory to the United Nations Global Compact (UNGC) and in compliance with other international policies, such as the International Bill of Human Rights, the UN Guiding Principles on Business and Human Rights (UNGPs), and the International Labour Organization's (ILO's) Declaration on Fundamental Principles and Rights at Work, we are committed to upholding global standards. Read more about our commitment for respecting human rights:   https://bit.ly/3ZLk0eU

In 2024, Astellas took a bold step forward in biotech innovation by launching two cutting-edge facilities on the U.S. coasts - the Astellas West Coast Innovation Center in South San Francisco and the Astellas Life Sciences Center in Cambridge, Massachusetts. These dynamic facilities are designed to fuel collaboration, push the boundaries of science, and deliver new treatments to patients worldwide. From #GeneTherapy for neuromuscular diseases to targeted protein degradation, our teams are tackling high unmet #medical needs through transformative approaches. Hear from Daniel Hoeppner, Head of Partnering and Data Management at the Astellas Life Sciences Center, and Molly Ryan, Neuromuscular Research Lead at the Astellas West Coast Innovation Center, as they share how these purpose-built facilities are driving cross-functional teamwork and spontaneous innovation every day. Read the full story here:  https://lnkd.in/gFXNrbfC #pharma #healthcare

Today is #WorldGADay. We stand with those impacted by #GeographicAtrophy, a progressive and irreversible retinal disease that affects over five million people globally and can lead to permanent vision loss and blindness. A few weeks ago, on World Sight Day, we challenged our team to reflect on our long-term commitment to people with vision loss by reflecting on the gift of sight and their most cherished views. Below is a snapshot of some of these special moments. #EyeHealth #ophthalmology #ChangingTomorrow #ScienceFirstForPatients